Healthcare provider profile · identity verified

Todd R Nelson, M.D.

Family Practice · BURLINGTON, WI · NPI 1457562126

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Warfarin Sodium	Warfarin Sodium	757	190
Atorvastatin Calcium	Atorvastatin Calcium	627	152
Rosuvastatin Calcium	Rosuvastatin Calcium	475	132
Losartan Potassium	Losartan Potassium	329	85
Amlodipine Besylate	Amlodipine Besylate	327	85
Lisinopril	Lisinopril	319	82
Levothyroxine Sodium	Levothyroxine Sodium	316	73
Omeprazole	Omeprazole	272	73
Hydrochlorothiazide	Hydrochlorothiazide	270	69
Pantoprazole Sodium	Pantoprazole Sodium	225	61
Gabapentin	Gabapentin	213	54
Metformin Hcl Er	Metformin Hcl	201	49
Tamsulosin Hcl	Tamsulosin Hcl	139	44
Metoprolol Succinate	Metoprolol Succinate	138	36
Allopurinol	Allopurinol	133	34
Albuterol Sulfate Hfa	Albuterol Sulfate	130	46
Sertraline Hcl	Sertraline Hcl	125	29
Jardiance	Empagliflozin	119	28
Metformin Hcl	Metformin Hcl	119	32
Simvastatin	Simvastatin	113	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	111	25
Furosemide	Furosemide	108	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	93	24
Metoprolol Tartrate	Metoprolol Tartrate	93	24
Tramadol Hcl	Tramadol Hcl	91	28
Ozempic	Semaglutide	90	17
Duloxetine Hcl	Duloxetine Hcl	85	20
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	79	19
Eliquis	Apixaban	76	20
Fluticasone Propionate	Fluticasone Propionate	74	21
Potassium Chloride	Potassium Chloride	71	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	16
Fluoxetine Hcl	Fluoxetine Hcl	65	16
Trazodone Hcl	Trazodone Hcl	63	16
Escitalopram Oxalate	Escitalopram Oxalate	60	12
Tizanidine Hcl	Tizanidine Hcl	52	15
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	52	suppressed
Montelukast Sodium	Montelukast Sodium	51	14
Pravastatin Sodium	Pravastatin Sodium	51	13
Diclofenac Sodium	Diclofenac Sodium	50	26
Bupropion Xl	Bupropion Hcl	48	17
Chlorthalidone	Chlorthalidone	47	15
Pregabalin	Pregabalin	47	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	47	11
Fenofibrate	Fenofibrate Nanocrystallized	45	suppressed
Alprazolam	Alprazolam	44	18
Carvedilol	Carvedilol	44	suppressed
Mirtazapine	Mirtazapine	44	suppressed
Baclofen	Baclofen	43	suppressed
Clonazepam	Clonazepam	43	suppressed
Celecoxib	Celecoxib	42	16
Glyxambi	Empagliflozin/Linagliptin	41	suppressed
Donepezil Hcl	Donepezil Hcl	40	suppressed
Famotidine	Famotidine	39	suppressed
Lorazepam	Lorazepam	39	suppressed
Meloxicam	Meloxicam	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	suppressed
Spironolactone	Spironolactone	38	12
Atenolol	Atenolol	37	11
Finasteride	Finasteride	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	15
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	31	suppressed
Glipizide	Glipizide	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Valsartan	Valsartan	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Jantoven	Warfarin Sodium	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Naproxen	Naproxen	22	suppressed
Ondansetron Odt	Ondansetron	22	13
Cephalexin	Cephalexin	21	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Azithromycin	Azithromycin	19	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	18
Lidocaine	Lidocaine	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Prednisone	Prednisone	16	14
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Digoxin	Digoxin	14	suppressed
Estradiol	Estradiol	14	suppressed
Pimozide	Pimozide	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Aripiprazole	Aripiprazole	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Testosterone	Testosterone	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Primidone	Primidone	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Nystatin	Nystatin	11	suppressed
Restasis	Cyclosporine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error